Cardiovascular and Thromboembolic Events Following Hypertensive Pregnancy

American Journal of Kidney Diseases

Volumn 42, Issue 5, 2003, Pages 982-989

  Kestenbaum, Bryan ^a   Seliger, Stephen L ^b   Easterling, Thomas R ^b   Gillen, Daniel L ^b   Critchlow, Cathy W ^b   Stehman Breen, Catherine O ^b   Schwartz, Stephen M ^b  

^a Division of Nephrology   (United States)

^b NONE

Author keywords

Hypertension; Myocardial infarction; Preeclampsia; Pregnancy; Stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD; PREECLAMPSIA; RISK ASSESSMENT; THROMBOEMBOLISM; UNITED STATES;

EID: 0142250926     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.07.001     Document Type: Article

References (38)

1. Lindmark G, Lindberg B, Hogstedt S: The incidence of hypertensive disease in pregnancy. Acta Obstet Gynecol Scand Suppl 118:29-32, 1984
2. Sibai BM: Hypertension in pregnancy, in Gabbe SG, Nieby JR, Simpson JL (eds): Obstetrics: Normal and Problem Pregnancies (ed 3). New York, NY, Churchill Livingstone, 1996, pp 935-996
3. Cunningham FMP, Gant N: Hypertensive disorders in pregnancy, in Cunningham FG, MacDonald PC, Gant NF (eds): Williams Obstetrics (ed 18). Norwalk, CT, Appleton & Lange, 1989, pp 654-694
4. Ananth CV, Peedicayil A, Savitz DA: Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology 6:391-395, 1995
5. McCowan LM, Buist RG, North RA, Gamble G: Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 103:123-129, 1996
6. Rey E, Couturier A: The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171:410-416, 1994
7. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155:501-509, 1986
8. VanWijk MJ, Boer K, van der Meulen ET, Bleker OP, Spaan JA, VanBavel E: Resistance artery smooth muscle function in pregnancy and preeclampsia. Am J Obstet Gynecol 186:148-154, 2002
9. Ashworth JR, Warren AY, Baker PN, Johnson IR: Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 104: 1152-1158, 1997
10. Lyall F, Hayman RG, Ashworth JR, Duffie E, Baker PN: Relationship of cell adhesion molecule expression to endothelium-dependent relaxation in normal pregnancy and pregnancies complicated with preeclampsia or fetal growth restriction. J Soc Gynecol Invest 6:196-201, 1999
11. Kupferminc MJ, Eldor A, Steinman N, et al: Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9-13, 1999
12. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP: Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol 76:1061-1069, 1990
13. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C: Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94:978-984, 1999
14. Marin R, Gorostidi M, Portal CG, Sanchez M, Sanchez E, Alvarez J: Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy 19:199-209, 2000
15. Sibai BM, el-Nazer A, Gonzalez-Ruiz A: Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 155:1011-1016, 1986
16. Sibai BM, Sarinoglu C, Mercer BM: Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 166:1757-1761, discussion 1761-1763, 1992
17. North RA, Simmons D, Barnfather D, Upjohn M: What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol 36:233-238, 1996
18. Smith GC, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births. Lancet 357:2002-2006, 2001
19. Hannaford P, Ferry S, Hirsch S: Cardiovascular sequelae of toxaemia of pregnancy. Heart 77:154-158, 1997
20. Tirschwell DL, Longstreth WT Jr: Validating administrative data in stroke research. Stroke 33:2465-2470, 2002
21. Rosamond WD, Folsom AR, Chambless LE, et al: Stroke incidence and survival among middle-aged adults: 9-Year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30:736-743, 1999
22. Petersen LA, Wright S, Normand SL, Daley J: Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 14:555-558, 1999
23. Cox D: Regression models and life tables. J R Stat Soc 34:187-220, 1972
24. Chesley SC, Annitto JE, Cosgrove RA: The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 124:446-459, 1976
25. Sibai BM, Mercer B, Sarinoglu C: Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 165:1408-1412, 1991
26. Roberts RN, Henriksen JE, Hadden DR: Insulin sensitivity in pre-eclampsia. Br J Obstet Gynaecol 105:1095-1100, 1998
27. Shanklin DR, Sibai BM: Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 161:735-741, 1989
28. Morris NH, Eaton BM, Dekker G: Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 103:4-15, 1996
29. Klockenbusch W, Goecke TW, Krussel JS, Tutschek BA, Crombach G, Schror K: Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia. Gynecol Obstet Invest 50:103-107, 2000
30. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171:944-948, 1994
31. Roberts JM, Taylor RN, Goldfien A: Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4:700-708, 1991
32. Davidge ST, Stranko CP, Roberts JM: Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174:1008-1013, 1996
33. Mills JL, DerSimonian R, Raymond E, et al: Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: A multicenter prospective study. JAMA 282: 356-362, 1999
34. Jacober SJ, Morris DA, Sowers JR: Postpartum blood pressure and insulin sensitivity in African-American women with recent preeclampsia. Am J Hypertens 7:933-936, 1994
35. Kim YJ, Williamson RA, Murray JC, et al: Genetic susceptibility to preeclampsia: Roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 184:1211-1217, 2001
36. van Walraven C, Wang B, Ugnat AM, Naylor CD: False-positive coding for acute myocardial infarction on hospital discharge records: Chart audit results from a tertiary centre. Can J Cardiol 6:383-386, 1990
37. Lidegaard O, Edstrom B, Kreiner S: Oral contraceptives and venous thromboembolism: A five-year national case-control study. Contraception 65:187-196, 2002
38. Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R: The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception 56:129-140, 1997